Trial Profile
A phase II study of Edratide (hCDR1) for the treatment of Sjogren's syndrome
Status:
Planning
Phase of Trial:
Phase II
Latest Information Update: 16 Feb 2017
Price :
$35
*
At a glance
- Drugs Edratide (Primary)
- Indications Sjogren's syndrome
- Focus Therapeutic Use
- 16 Feb 2017 New trial record